Deep Apple’s $52 million funding revolutionizing drug discovery
admin Deep Apple Therapeutics discovers the therapeutics for high-value targets through virtual screening of artificial intelligence (AI)-generated virtual libraries.…
Medicine
Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval
Up to 160 adults with increased risk for acute kidney injury (AKI) following cardiac surgery are planned to…
CellCentric gives hope to last-line multiple myeloma patients
UK-based biotech, CellCentric which spun out of Cambridge University has yesterday (December 11) announced new clinical data for…
CEO at Vector Laboratories’ instant passion for science
She discovered a passion for science after her very first chemistry lesson and found the subject came easily…
Neurological diseases focus of Pharmakure’s alliance with Malaysian university
The company will now work with the faculty of pharmacy at Universiti Teknologi MARA (UiTM) with the partnership…
HIV pathology data now reaching investigators within hours
Established in 1994 and funded by the National Institutes of Health and National Cancer Institution has opted to…
CellCentric gives hope to last-line multiple myeloma patients
UK-based biotech, CellCentric which spun out of Cambridge University has today (December 11) announced new clinical data for…
Merck launches SaaS platform with 60 billion possibilities
The Aiddison drug discovery software works through Synthia retrosynthesis software application programming interface (API) integration and Merck says…
Q&A: Univar Solutions – sourcing and distributing pharma ingredients
As director of strategic growth and technical sales plus pharmaceutical ingredients, she has given us a comprehensive overview.…
Piramal Pharma has launched a high-throughput screening facility
It will add to the existing in-vitro biology capabilities with the addition of primary and secondary screening capabilities…
ObvioHealth reveals new digital therapeutics API
There is an ongoing digital shift in clinical trials, and as a result, companies are continuously striving to…
Symbiosis granted MHRA license following £1 million investment
The CDMO has launched the new in-house analytical and microbiological capabilities that will enable the testing. Fully approved…
Takeda’s Adzynma approved for prophylactic and on-demand treatment of cTTP
Takeda announced at the end of last month (November 2023) that it had been approved by the US…
Roquette and Qualicaps combine to expand global footprint
Qualicaps manufactures hard capsules and pharmaceutical-related equipment and is the third-largest producer for oral dosage solutions. The company…
Interview: Enthought – the trials and tribulations of AI
There is still a general sense of wariness from some sectors within the life sciences and we discussed…
Yseop’s impactful Generative AI capabilities helping accelerate drugs to market
At the same time, the company has announced the closing of a strategic investment round with new investor…
How Zizi Uzezi ‘bridges the gap’ between healthcare solutions and patients
She has successfully guided many biotech and life science companies across their end-to-end clinical development journey and has…
How microgravity could transform pharma manufacturing
The California-based start-up claims that, by removing gravity, they are able to make medicines that are not viable…
‘Abstinence is not the only road to recovery’
BPR: What is Alcohol Use Disorder (AUD) and why is it a major health, social and financial problem?…
Merck signs $70 million deal to commercialize Abbisko’s new cancer drug in China
TGCT is a benign tumor of the joints that can cause swelling, pain, stiffness, and limited mobility of…
Pfizer axes new weight loss pill after patients experience serious side effects
While obese patients lost significant amounts of weight, many reported high rates of side effects such as nausea…
Exciting opportunity to design new antibody therapy using generative AI
Announced today (December 4), the agreement will combine Absci’s Integrated Drug Creation platform with AstraZeneca’s expertise in oncology,…
Pfizer and Astellas’ prostate cancer drug approved
This was following FDA expedited development and review programs (Priority Review designation, Fast Track designation, Real-time Oncology Review),…
Biotech startup Cradle raises $24 million Series A to accelerate AI technology
The round was led by Index Ventures with participation from Kindred Capital and takes the total raised by…
Progress for Johnson & Johnson’s lung cancer drug
The company is seeking approval of Rybrevant (amivantamab) in combination with chemotherapy (carboplatin and pemetrexed), a drug it…
Legalized medical cannabis in the UK five years on
The treatments are intended for a number of chronic health conditions including chronic pain, severe IBS, sleep disorders,…
Issues in data-monitoring for complex clinical trials
OSP: Can you tell us a bit more about the Sally Hollis Memorial Lecture? JV-R: The Sally Hollis…
Atropos Health forms Life Science Advisory Board with pharma experts
The life sciences advisory board indicates a continued focus on regulatory complaint and transparent methods for rapid and…
England’s vision for an end to new cases of HIV by 2030 is on track
PrEP (HIV Pre-exposure Prophylaxis) is a pre-exposure medicine – prophylaxis means to prevent infection and can reduce the…
First eye drop for diabetic macular oedema on horizon after successful trial
During the trial, EXN407 met all endpoints and displayed ‘encouraging’ biological activity in diabetic patients with retinal eye…
Call for volunteers to test ground-breaking psychedelic treatments
Clerkenwell Health, a leading provider of mental health research, has today (November 28) called for volunteers for the…
Issues in data-monitoring for complex clinical trials
OSP: Can you tell us a bit more about the Sally Hollis Memorial Lecture? JV-R: The Sally Hollis…
Hilleman Laboratories unveils $20 million Singapore facility to boost vaccine manufacturing
As a result, the company claims it is now the only multi-modality vaccine and biologics development and manufacturing…
Not to be missed – our patient centricity in action webinar
The webinar will be broadcasting on Wednesday, December 6 at 10am CST (Chicago) and 5pm CET (Paris) and…
1nhaler raises £2 million to develop single-use sustainable inhaler
Inhalable medicines are already widely used to treat conditions such as asthma, epilepsy, allergies and Parkinson’s but delivery…
‘The CDMO industry is not going away’
“Across the board, the CDMO industry has noticed the difference in the economy. There is a tightening of…
The future’s bright for Vetter
We met at CPHI in Barcelona to discuss how Vetter had coped through the pandemic and what the…
The future’s bright for Vetter
We met at CPHI in Barcelona to discuss how Vetter had coped through the pandemic and what the…
CluePoints wins prestigious accolade for commitment to innovation
The award was presented at The Dorchester in London, on Thursday last week (November 16), and the company…
Adragos Pharma’s Japanese site is ‘sweet spot’ among acquisitions
The company currently has four sites in Livron, France, Leipzig, Germany, Athens, Greece and Kawagoe, Japan. Most recently,…
Promising drug targets to be identified by game-changing technology
The Thermo Scientific Orbitrap Astral Mass Spectrometer (MS) will be located at MIPS in Parkville and is the…
Calliditas and Everest announce kidney drug approval
Nefecon is designed for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease…
CellCentric publishes new ways to treat specific blood cancers
CellCentric, a UK-based biotechnology company, announced today (November 22) the publication of the paper and how the work…
Adragos Pharma’s Japanese site is ‘sweet spot’ among acquisitions
The company currently has four sites in Livron, France, Leipzig, Germany, Athens, Green and Kawagoe, Japan. Most recently,…
Flywheel and Microsoft collaborate to unlock powerful data
Flywheel, a leading medical imaging artificial intelligence (AI) development platform, today announced the launch of its software-as-a-service (SaaS)…